News
-
-
COMMUNIQUÉ DE PRESSE
Dahua Technology Releases 2025 ESG Report: Advancing Sustainable Development Through Digital Intelligence
Dahua Technology releases its 2025 ESG Report focusing on sustainable development through digital intelligence, highlighting achievements in ESG strategies, AIoT innovation, green development, and governance practices -
COMMUNIQUÉ DE PRESSE
The Fresh Factory Reports Fiscal 2025 Results with Record Annual Billed Revenue of $45.1M, EBITDA increase of 225% YoY
The Fresh Factory B.C. Ltd. announces record revenue and positive EBITDA growth for 2025. They increased lending facility and commenced facility retrofit for capacity expansion -
COMMUNIQUÉ DE PRESSE
Eskay Mining Corp. Establishes Rapid Turnaround Analytical Laboratory in Stewart, BC to Accelerate Gold Discovery using detectORE(TM) Technology
Eskay Mining Corp. establishes a new rapid turnaround analytical laboratory in Stewart, BC to accelerate gold exploration in British Columbia's Golden Triangle -
-
-
COMMUNIQUÉ DE PRESSE
mbiomics Announces Third Closing of Series A, Reaching €30 Million to Advance Microbiome Therapeutics
mbiomics announces successful third closing of Series A funding round, raising €30 million to advance microbiome therapeutics, focusing on clinical evaluation of lead candidate MBX-116 for advanced melanoma -
COMMUNIQUÉ DE PRESSE
Meta Critical Minerals Signs Option Agreement To Acquire High-Grade U.S. Critical Minerals Project Covering Two Historical Deposits Rich in Zircon, Titanium and Rare Earths
Meta Critical Minerals Inc., formerly Troy Minerals Inc., announces option to purchase Arcadia Minerals Inc.'s critical minerals projects in Wyoming, USA. Strong infrastructure, high-grade zircon, ilmenite, monazite deposits with significant exploration potential -
-
COMMUNIQUÉ DE PRESSE
Immunic Appoints Accomplished Biopharmaceutical Executive Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer
Immunic appoints Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer, bringing extensive experience in neurology drug development and regulatory approvals. Company transitions into a fully integrated commercial-stage entity
